Anti-proliferative effect of glucocorticoids on mesenchymal cells in juvenile angiofibromas

Head and Neck

Volumn 34, Issue 11, 2012, Pages 1615-1621

  Wendler, Olaf ^a   Dlugaiczyk, Julia ^b   Birk, Stephanie ^a   Schick, Bernhard ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

dexamethasone; glucocorticoid receptor; juvenile angiofibroma; nasal mucosa; proliferation

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; PREDNISOLONE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MESENCHYME CELL; NASOPHARYNX FIBROMA; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA; STROMA CELL; TUMOR VOLUME;

ANGIOFIBROMA; CELL PROLIFERATION; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOCORTICOIDS; HUMANS; MESENCHYMAL STROMAL CELLS; NASAL MUCOSA; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 84867887213     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21966     Document Type: Article

References (45)

1. Glad H, Vainer B, Buchwald C, et al. Juvenile nasopharyngeal angiofibromas in Denmark 1981-2003: diagnosis, incidence and treatment. Acta Otolaryngol 2007; 127: 292-299.
2. Schick B, Kahle G,. Radiological findings in angiofibroma. Acta Radiol 2000; 41: 585-593.
3. Gatalica Z,. Immunohistochemical analysis of steroid hormone receptors in nasopharyngeal angiofibromas. Cancer Lett 1998; 127: 89-93.
4. Hwang HC, Mills SE, Patterson K, Gown AM,. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol 1998; 11: 1122-1126.
5. Montag AG, Tretiakova M, Richardson M,. Steroid hormone receptor expression in nasopharyngeal angiofibromas. Consistent expression of estrogen receptor beta. Am J Clin Pathol 2006; 125: 832-837.
6. Saylam G, Yücel OT, Sungur A, Onerci M,. Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma. Int J Pediatr Otorhinolaryngol 2006; 70: 227-234.
7. Schick B, Rippel C, Brunner C, Jung V, Plinkert PK, Urbschat S,. Numerical sex chromosome aberrations in juvenile angiofibromas: genetic evidence for an androgen-dependent tumor? Oncol Rep 2003; 10: 1251-1255.
8. Coutinho-Camillo CM, Brentani MM, Nagai MA,. Genetic alterations in juvenile nasopharyngeal angiofibromas. Head Neck 2008; 30: 390-400.
9. Brentani MM, Butugan O, Oshima CT, Torloni H, Paiva LJ,. Multiple steroid receptors in nasopharyngeal angiofibromas. Laryngoscope 1989; 99: 398-401.
10. Oakley RH, Cidlowski JA,. Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J Biol Chem 2011; 286: 3177-3184.
11. Greenstein S, Ghias K, Krett NL, Rosen ST,. Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. Clin Cancer Res 2002; 8: 1681-1694.
12. Chebotaev D, Yemelyanov A, Budunova I,. The mechanisms of tumor suppressor effect of glucocorticoid receptor in skin. Mol Carcinog 2007; 46: 732-740.
13. Frankfurt O, Rosen ST,. Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updates. Curr Opin Oncol 2004; 16: 553-563.
14. Schick B, Wemmert S, Willnecker V, et al. Genome-wide copy number profiling using a 100K SNP array reveals novel disease-related genes BORIS and TSHZ1 in juvenile angiofibroma. Int J Oncol 2011; 39: 1143-1151.
15. Andrews JC, Fisch U, Aeppli U, Valavanis A, Makek MS,. The surgical management of extensive nasopharyngeal angiofibromas with the infratemporal fossa approach. Laryngoscope 1989; 99: 429-437.
16. Schick B, Wemmert S, Jung V, Steudel WI, Montenarh M, Urbschat S,. Genetic heterogeneity of the MYC oncogene in advanced juvenile angiofibromas. Cancer Genet Cytogenet 2006; 164: 25-31.
17. Gramann M, Wendler O, Haeberle L, Schick B,. Prominent collagen type VI expression in juvenile angiofibromas. Histochem Cell Biol 2009; 131: 155-164.
18. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034.
19. Wendler O, Schaefer R, Schick B,. Mast cells and T-lymphocytes in juvenile angiofibromas. Eur Arch Otorhinolaryngol 2007; 264: 769-775.
20. Pauli J, Gundelach R, Vanelli-Rees A, et al. Juvenile nasopharyngeal angiofibroma: an immunohistochemical characterisation of the stromal cell. Pathology 2008; 40: 396-400.
21. Eivazi B, Ardelean M, Bäumler W, et al. Update on hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol 2009; 266: 187-197.
22. Pujols L, Mullol J, Roca-Ferrer J, et al. Expression of glucocorticoid receptor alpha- and beta-isoforms in human cells and tissues. Am J Physiol Cell Physiol 2002; 283: C1324-C1331.
23. Dillard DG, Cohen C, Muller S, et al. Immunolocalization of activated transforming growth factor beta1 in juvenile nasopharyngeal angiofibroma. Arch Otolaryngol Head Neck Surg 2000; 126: 723-725.
24. Coutinho-Camillo CM, Brentani MM, Butugan O, Torloni H, Nagai MA,. Relaxation of imprinting of IGFII gene in juvenile nasopharyngeal angiofibromas. Diagn Mol Pathol 2003; 12: 57-62.
25. Camilli TC, Weeraratna AT,. Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression. Biochem Pharmacol 2010; 80: 702-711.
26. Takayama S, Rogatsky I, Schwarcz LE, Darimont BD,. The glucocorticoid receptor represses cyclin D1 by targeting the Tcf-beta-catenin complex. J Biol Chem 2006; 281: 17856-17863.
27. Abraham SC, Montgomery EA, Giardiello FM, Wu TT,. Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas. Am J Pathol 2001; 158: 1073-1078.
28. Labra A, Chavolla-Magaña R, Lopez-Ugalde A, Alanis-Calderon J, Huerta-Delgado A,. Flutamide as a preoperative treatment in juvenile angiofibroma (JA) with intracranial invasion: report of 7 cases. Otolaryngol Head Neck Surg 2004; 130: 466-469.
29. Thakar A, Gupta G, Bhalla AS, et al. Adjuvant therapy with flutamide for presurgical volume reduction in juvenile nasopharyngeal angiofibroma. Head and Neck 2011 [Epub ahead of print].
30. Gates GA, Rice DH, Koopmann CF Jr, Schuller DE,. Flutamide-induced regression of angiofibroma. Laryngoscope 1992; 102: 641-644.
31. Küttner K, Katenkamp D, Stiller D,. Hormone therapy of the juvenile angiofibroma. Arch Otorhinolaryngol 1977; 214: 331-338.
32. Hulthen UL, Toremalm NG,. Juvenile nasopharyngeal angiofibroma. J Otolaryngol 1976; 5: 55-63.
33. Basaria S, Lieb J II, Tang AM, et al. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol 2002; 56: 779-786.
34. Heitzer MD, Wolf IM, Sanchez ER, Wichtel SF, DeFranco DB,. Glucocorticoid receptor physiology. Rev Endocr Metab Disord 2007; 8: 321-330.
35. Conde I, Paniagua R, Fraile B, Lucio J, Arenas MI,. Glucocorticoid receptor changes its cellular location with breast cancer development. Histol Histopathol 2008; 23: 77-85.
36. Shiratsuchi T, Ishibashi H, Shirasuna K,. Inhibition of epidermal growth factor-induced invasion by dexamethasone and AP-1 decoy in human squamous cell carcinoma cell lines. J Cell Physiol 2002; 193: 340-348.
37. Duerr S, Wendler O, Aigner T, Karosi S, Schick B,. Metalloproteinases in juvenile angiofibroma - a collagen rich tumor. Hum Pathol 2008; 39: 259-268.
38. Dourmishev LA, Dourmishev AL,. Craniofacial cavernous hemangioma: successful treatment with methylprednisolone. Acta Dermatovenerol Alp Panonica Adriat 2005; 14: 49-52.
39. Oliver A, Ciulla TA,. Corticosteroids as antiangiogenic agents. Ophthamol Clin North Am 2006; 19: 345-351.
40. Yano A, Fujii Y, Iwai A, Kageyama Y, Kihara K,. Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells. Clin Cancer Res 2006; 12: 3003-3009.
41. Brieger J, Wierzbicka M, Sokolov M, Roth Y, Szyfter W, Mann WJ,. Vessel density, proliferation and immunolocalization of vascular endothelial growth factor in juvenile nasopharyngeal angiofibromas. Arch Otolaryngol Head Neck Surg 2004; 130: 727-731.
42. Zhang M, Sun X, Yu H, Hu L, Wang D,. Biological distinctions between juvenile nasopharyngeal angiofibroma and vascular malformation: an immunohistochemical study. Acta Histochem 2011; 113: 626-630.
43. Kasselman LJ, Kinter J, Sideris A, et al. Dexamethasone treatment and ICAM-1 deficiency impair VEGF-induced angiogenesis in adult brain. J Vasc Res 2007; 44: 283-291.
44. Ahmad N, Kumar R,. Steroid hormone receptors in cancer development: a target for cancer therapeutics. Cancer Lett 2011; 300: 1-9.
45. Piette C, Munaut C, Foidart JM, Deprez M,. Treating gliomas with gluococorticoids: from bedside to bench. Acta Neuropathol 2006; 112: 651-664.